0001237899-18-000026.txt : 20181220
0001237899-18-000026.hdr.sgml : 20181220
20181220173643
ACCESSION NUMBER: 0001237899-18-000026
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181219
FILED AS OF DATE: 20181220
DATE AS OF CHANGE: 20181220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fenimore Christopher R.
CENTRAL INDEX KEY: 0001697422
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 181247103
MAIL ADDRESS:
STREET 1: REGENERON PHARMACEUTICALS, INC.
STREET 2: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2018-12-19
0
0000872589
REGENERON PHARMACEUTICALS INC
REGN
0001697422
Fenimore Christopher R.
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
VP Controller
Common Stock
2018-12-19
4
M
0
3450
52.03
A
9871
D
Common Stock
2018-12-19
4
F
0
1602
364.42
D
8269
D
Common Stock
2018-12-20
4
M
0
675
21.25
A
8944
D
Common Stock
2018-12-20
4
S
0
100
355.14
D
8844
D
Common Stock
2018-12-20
4
S
0
348
356.27
D
8496
D
Common Stock
2018-12-20
4
S
0
200
357.5
D
8296
D
Common Stock
2018-12-20
4
S
0
200
358.27
D
8096
D
Common Stock
2018-12-20
4
S
0
200
359.38
D
7896
D
Common Stock
2018-12-20
4
S
0
500
360.4
D
7396
D
Common Stock
2018-12-20
4
S
0
100
361.65
D
7296
D
Common Stock
2018-12-20
4
S
0
200
362.45
D
7096
D
Common Stock
1349
I
By 401(k) Plan
Common Stock
1397
I
By Trust
Common Stock
1424
I
by 2017 GRAT
Common Stock
2950
I
by 2018 GRAT
Incentive Stock Option (right to buy)
21.25
2018-12-20
4
M
0
675
0.0
D
2019-12-18
Common Stock
675
500
D
Non-Qualified Stock Option (right to buy)
52.03
2018-12-19
4
M
0
3450
0.0
D
2021-12-16
Common Stock
3450
10326
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 348 shares of Company stock on December 20, 2018 at prices ranging from $356.22 to $356.34. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 20, 2018 at each separate price.
Represents volume-weighted average price of sales of 200 shares of Company stock on December 20, 2018 at prices ranging from $357.15 to $357.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 20, 2018 at each separate price.
Represents volume-weighted average price of sales of 200 shares of Company stock on December 20, 2018 at prices ranging from $358.18 to $358.35. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 20, 2018 at each separate price.
Represents volume-weighted average price of sales of 200 shares of Company stock on December 20, 2018 at prices ranging from $359.18 to $359.57. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 2018 at each separate price.
Represents volume-weighted average price of sales of 500 shares of Company stock on December 20, 2018 at prices ranging from $360.18 to $360.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 20, 2018 at each separate price.
Represents volume-weighted average price of sales of 200 shares of Company stock on December 20, 2018 at prices ranging from $362.02 to $362.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 20, 2018 at each separate price.
These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.
The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
/s/**Christopher R. Fenimore
2018-12-20